These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1283171)

  • 41. Biochemical and immunohistochemical analyses of keratin expression in basal cell carcinoma.
    Yoshikawa K; Katagata Y; Kondo S
    J Dermatol Sci; 1998 May; 17(1):15-23. PubMed ID: 9651824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor receptors in human epidermal tumours.
    Nazmi MN; Dykes PJ; Marks R
    Br J Dermatol; 1990 Aug; 123(2):153-61. PubMed ID: 2205281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
    Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
    J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The basal lamina in basal cell carcinoma, Bowen's disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV collagen.
    McArdle JP; Roff BT; Muller HK; Murphy WH
    Pathology; 1984 Jan; 16(1):67-72. PubMed ID: 6371685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carcinoembryonic antigen in skin and related tumours as determined by immunohistological techniques.
    Scurry J; de Boer WG
    Pathology; 1983 Oct; 15(4):379-84. PubMed ID: 6371679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of activating transcription factor 3 is related to the biologic behavior of cutaneous squamous cell carcinomas.
    Kim MS; In SG; Park OJ; Won CH; Lee MW; Choi JH; Kim CW; Kim SE; Moon KC; Chang S
    Hum Pathol; 2011 Jul; 42(7):954-9. PubMed ID: 21315420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monospecific monoclonal antibodies to keratin 1 carboxy terminal (synthetic peptide) and to keratin 10 as markers of epidermal differentiation.
    Leigh IM; Purkis PE; Whitehead P; Lane EB
    Br J Dermatol; 1993 Aug; 129(2):110-9. PubMed ID: 7544603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of differentiation-related expression of keratin 10 in early stages of vulvar squamous carcinoma.
    Ivanyi D; Ansink A; Mooi WJ; de Kraker NW; Heintz AP
    Differentiation; 1989 Dec; 42(2):124-9. PubMed ID: 2483838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive alterations of cytokeratin expressions in the process of chronic arsenism.
    Yu HS; Chiou KS; Chen GS; Yang RC; Chang SF
    J Dermatol; 1993 Dec; 20(12):741-5. PubMed ID: 7509818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions.
    Prieto VG; Lugo J; McNutt NS
    J Cutan Pathol; 1996 Jun; 23(3):234-41. PubMed ID: 8793658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of keratin proteins in deeply invasive basal and squamous cell carcinoma: an immunohistochemical study.
    Robinson JK
    J Dermatol Surg Oncol; 1987 Mar; 13(3):283-94. PubMed ID: 2434541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): immunohistochemical profile in comparison to normal hair follicles.
    Misago N; Toda S; Narisawa Y
    Am J Dermatopathol; 2012 Jun; 34(4):394-9. PubMed ID: 22452951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical study of cyclooxygenase-2 in skin tumors.
    Amirnia M; Babaie-Ghazani A; Fakhrjou A; Khodaeiani E; Alikhah H; Naghavi-behzad M; Zarrintan A
    J Dermatolog Treat; 2014 Oct; 25(5):380-7. PubMed ID: 22667343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study.
    Said JW; Sassoon AF; Shintaku IP; Banks-Schlegel S
    J Invest Dermatol; 1984 May; 82(5):449-52. PubMed ID: 6210326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-keratin monoclonal antibody against basal cell epithelioma keratin: BKN-1.
    Shimizu N; Ito M; Tazawa T; Katsuumi K; Sato Y
    J Dermatol; 1987 Aug; 14(4):359-63. PubMed ID: 2447138
    [No Abstract]   [Full Text] [Related]  

  • 56. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections.
    Szekeres G; De Giacomoni P
    Acta Derm Venereol; 1994 Mar; 74(2):95-7. PubMed ID: 7911636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
    Ichikawa E; Ohnishi T; Watanabe S
    J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes.
    Weiss RA; Eichner R; Sun TT
    J Cell Biol; 1984 Apr; 98(4):1397-406. PubMed ID: 6201492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma.
    Smedts F; Ramaekers F; Leube RE; Keijser K; Link M; Vooijs P
    Am J Pathol; 1993 Feb; 142(2):403-12. PubMed ID: 7679549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.